Fluoroquinolone antibiotic. Inhibits bacterial type II topoisomerases (IC50 values are 0.109 and 13.8 μg/ml for E.coli DNA gyrase and S.aureus topoisomerase IV respectively). Displays potent activity against gram-positive and gram-negative bacteria. Stimulates short-term self-renewal in both human and mouse embryonic stem cells in vitro.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|DMSO||3.75||10 with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 375.39. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||26.64 mL||133.19 mL||266.39 mL|
|0.5 mM||5.33 mL||26.64 mL||53.28 mL|
|1 mM||2.66 mL||13.32 mL||26.64 mL|
|5 mM||0.53 mL||2.66 mL||5.33 mL|
References are publications that support the biological activity of the product.
Takei et al (1998) Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases. Antimicrob.Agents Chemother. 42 2678 PMID: 9756776
Desbordes et al (2008) High throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells. Cell Stem Cell 2 602 PMID: 18522853
Fukuda et al (1998) Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus. Antimicrob.Agents Chemother. 42 1917 PMID: 9687384
If you know of a relevant reference for Gatifloxacin, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Gatifloxacin, Gatifloxacin supplier, potent, inhibitors, inhibits, DNA, gyrase, topoisomerase, IV, gatifloxacin, AM1155, fluoroquinolone, antibacterial, antibiotics, stem, cells, AM, 1155, DNA,, RNA, and, Protein, Synthesis, Stem, Cell, Proliferation, Topoisomerase, Antibiotics, 3849, Tocris Bioscience
Citations for Gatifloxacin
Citations are publications that use Tocris products.
Currently there are no citations for Gatifloxacin. Do you know of a great paper that uses Gatifloxacin from Tocris? Please let us know.
Reviews for Gatifloxacin
Average Rating: 5 (Based on 1 Review.)
Have you used Gatifloxacin?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Gatifloxacin was used to understand its resistance pattern against S. aureus. E. coli strains were grown in Luria-Bertani medium, and S. aureus strains were grown in brain heart infusion medium for resistance study.
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.